Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells. 2009

Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Department of Life and Health Sciences, Teikyo University of Science and Technology, Biotechnology Research Center, Teikyo University of Science and Technology, Uenohara, Yamanashi 409-0193, Japan.

In order to study telomerase activation in normal cells, a telomerase-immortalized fibroblast cell line, hTERT-BJ1, treated with a telomerase inhibitor, 3'-azido-2',3'-dideoxyguanosine (AZddG), is considered to be a good model. Long-term treatment with AZddG resulted in telomere shortening from 10-20 kbp to 5-6 kbp in cultured hTERT BJ1 cells. However, the telomere length then stabilized. As expected, removal of AZddG from the culture medium induced telomere lengthening in the cells, suggesting that telomerase activity was recovered upon AZddG removal. The effect of recovery of telomerase activity in hTERT-BJ1 cells will be investigated in future studies.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D016615 Telomere A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Telomeres
D019098 Telomerase An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES. Telomerase Catalytic Subunit,Telomerase Reverse Transcriptase,Telomerase Reverse Transcriptase Catalytic Subunit,Catalytic Subunit, Telomerase,Reverse Transcriptase, Telomerase,Subunit, Telomerase Catalytic,Transcriptase, Telomerase Reverse

Related Publications

Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
June 2008, Oncology reports,
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
May 2004, DNA and cell biology,
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 1990, Biochemical and biophysical research communications,
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2007, Nucleosides, nucleotides & nucleic acids,
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
September 2002, Odontology,
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2004, Nucleosides, nucleotides & nucleic acids,
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2017, Journal of Ayurveda and integrative medicine,
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
June 1987, Biochemical and biophysical research communications,
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
January 2006, Nucleic acids symposium series (2004),
Yuichi Kurashina, and Xiaohong Liu, and Chiemi Kato, and Naoki Inoue, and Mineo Saneyoshi, and Toyofumi Yamaguchi
November 1998, International journal of oncology,
Copied contents to your clipboard!